Related Experiment Video

Updated: May 5, 2026

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
08:27

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury

Published on: May 21, 2018

10.1K

Severe asthma is associated with a loss of LX4, an endogenous anti-inflammatory compound

Isabelle Vachier1, Caroline Bonnans, Claude Chavis

  • 1Clinique des Maladies Respiratoires, CHU, Montpellier, France.

The Journal of Allergy and Clinical Immunology
|January 8, 2005
PubMed
Abstract

Insights

Induced sputum analysis revealed elevated levels of lipoxins and 15-epi-lipoxins in asthma patients. These findings offer insights into airway inflammation and mediator imbalance in severe asthma.

Area of Science:

  • Pulmonary Medicine
  • Inflammation Biology
  • Respiratory Pharmacology

Background:

  • Lipoxins and 15-epi-lipoxins are key lipid mediators regulating leukocyte trafficking and inflammation resolution.
  • Severe asthma is characterized by persistent airway inflammation unresponsive to standard therapies like oral glucocorticoids.

Purpose of the Study:

  • To quantify proinflammatory and anti-inflammatory mediators in induced sputum supernatants.
  • To investigate the presence of lipoxins and 15-epi-lipoxins in patients with varying asthma severity and COPD.

Main Methods:

  • Induced sputum supernatants were collected from healthy individuals and patients with mild, moderate, severe asthma, and COPD.
  • Validated immunoenzymatic methods were used to measure Interleukin-8 (IL-8), leukotriene B4 (LTB4), lipoxin A4 (LXA4), and 15-epi-lipoxin A4 (15-epi-LXA4).

Main Results:

  • IL-8 and LTB4 levels were significantly elevated in severe asthma and COPD patients.
  • Lipoxin A4 was increased in mild asthma, while 15-epi-lipoxin A4 was higher in severe asthma.
  • A positive correlation was observed between lipoxin A4 and IL-8 in mild asthma patients.

Conclusions:

  • Induced sputum is a viable method for measuring lipoxins and 15-epi-lipoxins in the respiratory tract.
  • Understanding the synthesis pathways of these eicosanoids is crucial for addressing the mediator imbalance in severe asthma.
  • Lipoxin production involves lipoxygenase interactions, while 15-epi-lipoxin synthesis may involve CytP450 activity.

More Related Videos

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

7.0K
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

4.7K

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.2K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
311
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
73